Tilaknagar Industries Q1 FY27: July 27 Results, Call

What the company has announced

Tilaknagar Industries Limited has informed investors that its board of directors will meet on Monday, July 27, 2026. The agenda is to evaluate and approve the standalone and consolidated unaudited financial results for the quarter ended June 30, 2026. This board meeting is the formal corporate event that anchors the company’s Q1 FY27 reporting cycle. The update comes as the July-August 2026 quarterly results season builds across NSE and BSE-listed companies.

Alongside the board-meeting disclosure, an earnings conference call has also been communicated for July 28, 2026 at 11:30 AM IST. The time and date are stated in the source alert and were flagged as not independently verified in the provided text. Even with that caveat, the call schedule is being positioned as the forum where management will discuss the quarter and take questions from analysts and investors.

Key dates investors are tracking

The most concrete milestone is the July 27, 2026 board meeting, which is explicitly confirmed in the company’s communication. The quarter under review is Q1 FY 2026-2027 (ended June 30, 2026). The follow-up earnings call is presented as a post-results interaction, intended to provide additional context beyond the financial statements.

The same dataset also frames the broader “results date” as July-August 2026 (indicative), which reflects the wider earnings season window. In practice, the July 27 board meeting remains the definitive event in the information provided. Investors typically watch for when filings and supporting documents are uploaded, and the company has said related documents will be available on its website.

Volume momentum entering Q1 FY27

The company enters Q1 FY27 with what the provided text describes as significant volume momentum. It reported record sales of 3.4 million cases in June 2026. It also reported over 3 million cases in May 2026. These volume datapoints are presented as recent operating indicators as the quarter began.

Such monthly case sales disclosures are often used by the market as near-term demand signals in alcoholic beverages and spirits, particularly when quarterly results are still pending. In this case, the numbers are presented as operational highlights ahead of the Q1 FY27 financial release.

Imperial Blue and TSMA exit update

A key operational change cited is Tilaknagar Industries’ exit from the Transition Services and Manufacturing Agreement (TSMA) for approximately 75% of the Imperial Blue business. The timeline given is “as of the start of Q1 FY27.” This is presented as a material development as the company transitions out of an earlier arrangement related to the Imperial Blue business.

The text does not provide a quantified impact of the TSMA exit on revenue, margins, or costs for Q1 FY27. However, it is included as an important context point for interpreting financial statements and commentary when the company reports.

Conference call details and access

The company has scheduled an earnings conference call on July 28, 2026 at 11:30 AM IST to discuss Q1 FY27 performance, as stated in the source alert. Senior management, including the Chairman and CFO, are expected to address analysts and investors. The company has also shared dial-in details for domestic and international participants.

The primary dial-in numbers listed are +91 22 6280 1141 and +91 22 7115 8042. For Singapore, a toll-free number 800 101 2045 is included. The company also states that the financial results and related documents will be made available on its corporate website at https://www.tilind.com.

Market snapshot: price, market cap, debt and recent reference points

The provided dataset includes multiple price and market-cap references. In the “Quick Details,” the CMP is listed as ₹441.25, with a market capitalisation of ₹10,919.77 crore and latest-quarter net debt of ₹1,934 crore. Elsewhere, the text also notes the shares trading at ₹455 with a market capitalisation of ₹11,243 crore and a price-to-earnings multiple of 540.8.

It also lists a 52-week range of ₹335.40 to ₹550.00, and a “Today” band of ₹430.35 to ₹441.40 in the provided snapshot. These figures reflect the market context around the announcement, as reproduced in the source text.

Street expectations and the stated estimate framework

An estimates table in the provided content lays out a Q1 FY27E revenue range of ₹1,211 to ₹1,393 crore and a PAT estimate range of ₹39 to ₹50 crore. A separate line also carries a 12-month target range of ₹546 to ₹605 attributed to “Uniresearch Estimate.” The same section notes that Tilaknagar Industries enters the results season trading around ₹455.

The estimate framework is described as a “trailing-growth” approach applied to a Q1 FY26 base of ₹868 crore revenue and ₹89 crore net profit, using the most recent year-on-year growth signal from Q4 FY26. The text also states that Q1 FY27 results are expected in the July-August 2026 window, consistent with the broader results season.

What recent quarterly numbers show in the provided tables

The dataset contains a quarterly table (figures in ₹ crore) with a “Jun 25” period showing total revenue of ₹863.87 crore, operating income of ₹87.18 crore, and net income of ₹88.51 crore. In the same table, “Mar 26” shows total revenue of ₹2,090.12 crore and net income of -₹14.91 crore. The table also includes a diluted normalized EPS of ₹4.54 for “Jun 25” and ₹1.92 for “Mar 26.”

Separately, another table for “Quarterly - Tilaknagar Industries Ltd.” lists net sales turnover of ₹409.14 crore for Jun’25 and ₹405.81 crore for Mar’25, along with EBITDA of ₹98.16 crore for Jun’25 and ₹86.12 crore for Mar’25, and reported PAT of ₹88.47 crore for Jun’25. The same provided text also includes a narrative block stating net revenue from operations of ₹409.1 crore for the quarter ended June 30, 2025 and PAT excluding exceptional items of ₹88.5 crore.

Summary table: dates, snapshot and estimates (as provided)

Why this update matters for investors

The immediate relevance is procedural but important: a scheduled board meeting on July 27 signals when the company expects to finalise and approve Q1 FY27 financials. For investors tracking Tilaknagar Industries into results season, the update tightens the timeline for filings, commentary, and any follow-on disclosures.

The operational datapoints on case volumes, along with the TSMA exit for a large portion of the Imperial Blue business, form the key context investors may use when reading the Q1 FY27 numbers. The market snapshot and the stated estimate ranges highlight that expectations and positioning are already part of the narrative ahead of the formal release.

Conclusion

Tilaknagar Industries’ board meeting on July 27, 2026 is the confirmed event for approval of Q1 FY27 unaudited standalone and consolidated results for the quarter ended June 30, 2026. A management discussion is also slated for July 28, 2026 at 11:30 AM IST, as stated in the source alert, alongside published dial-in details and a link to the company website for result documents. Investors will be watching the filings and management commentary against the stated volume momentum and the estimate ranges cited in the provided dataset.